The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases

Hepatology

Volumn 47, Issue 2, 2008, Pages 762-763

  Adler, Michael ^a   Gulbis, Béatrice ^a   Moreno, Christophe ^a   Evrard, Sylvie ^a   Verset, Gontran ^a   Golstein, Philippe ^a   Frotscher, Brigitte ^a   Nagy, Nathalie ^a   Thiry, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALCOHOL LIVER DISEASE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CHRONIC LIVER DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; HEPATITIS B; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LETTER; LIVER DISEASE; LIVER FIBROSIS; PRIORITY JOURNAL; SCORING SYSTEM;

HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; VIRAL LOAD;

EID: 39549108871     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22085     Document Type: Letter

References (9)

1. Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007;381:107-113.
2. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. HEPATOLOGY 2007;46:32-36.
3. Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007;46:775-782.
4. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. HEPATOLOGY 2007;45:297-306.
5. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006;52:1887-1896.
6. Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, et al.; LIDO Study Group; CYTOL study group. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:6.
7. Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005;3:167-174.
8. Myets RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, et al. Prediction of livet histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222-230.
9. Recommandation de Pratique Clinique: Critères diagnostiques et bilan initial de la cirrhose non compliquée. [Practical Clinical Recommendation: Diagnostic criteria and initial assessment of noncomplicated cirrhosis.] Published January 19, 2007. Available at: www.hassante.fr